GPX4-IN-9

Overview

GPX4-IN-9 (Compound A16) is a glutathione peroxidase 4 ( GPX4 ) inhibitor that specifically targets GPX4 under both in vitro and in vivo conditions, inducing ferroptosis . GPX4-IN-9 exhibits cytotoxicity against pancreatic cancer cells and can be used in cancer research.

Application

Products | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Pancreatic Cancer | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Glutathione Peroxidase | Products > Signaling Pathways > Ferroptosis

Product Information

• Catalog No.: HY-157762
• CAS No.: 3032746-99-6
• Molecular Formula: C26H21N3O2S2
• Molecular Weight: 471.59
• Purity: 99.18%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (5.30 mM); Clear solution
• Availability: In-stock

Source

Original product source